US Stock Movement | Revolution plunges 23% pre-market as Merck reportedly ends acquisition talks
Show original
Gelonghui, January 26｜According to sources, Merck has halted acquisition talks with biotechnology company Revolution Medicines due to the two parties' failure to reach an agreement on the purchase price. The report stated that the deal could have valued Revolution Medicines at around $30 billions. The report also added that negotiations could resume in the future, or other bidders may emerge.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
PoolX: Earn new token airdrops
Lock your assets and earn 10%+ APR
Lock now!
You may also like
International oil prices rose on the 4th
金十•2026/03/04 21:35
Semiconductor ETF closed up 2%, leading US stock sector ETFs
华尔街见闻•2026/03/04 21:17
Major capital moves in the field of quantum computing
老虎证券•2026/03/04 21:12
Trending news
MoreCrypto prices
More
Bitcoin
BTC
$73,202.2
+7.50%
Ethereum
ETH
$2,148.66
+9.12%
Tether USDt
USDT
$1
+0.02%
BNB
BNB
$659.44
+4.66%
XRP
XRP
$1.45
+7.28%
USDC
USDC
$0.9998
-0.03%
Solana
SOL
$92.51
+9.46%
TRON
TRX
$0.2873
+2.38%
Dogecoin
DOGE
$0.1021
+14.90%
Cardano
ADA
$0.2793
+6.70%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now